- Home
- PED vs NBY Comparison
PED vs NBY Comparison
Compare PED & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- NBY
- Stock Information
- Founded
- PED N/A
- NBY 2000
- Country
- PED United States
- NBY United States
- Employees
- PED N/A
- NBY N/A
- Industry
- PED Oil & Gas Production
- NBY
- Sector
- PED Energy
- NBY
- Exchange
- PED Nasdaq
- NBY Nasdaq
- Market Cap
- PED N/A
- NBY 3.5M
- IPO Year
- PED N/A
- NBY 2007
- Fundamental
- Price
- PED $0.98
- NBY $0.68
- Analyst Decision
- PED Strong Buy
- NBY
- Analyst Count
- PED 2
- NBY 0
- Target Price
- PED $2.00
- NBY N/A
- AVG Volume (30 Days)
- PED 101.7K
- NBY 7.7M
- Earning Date
- PED 11-07-2024
- NBY 11-07-2024
- Dividend Yield
- PED N/A
- NBY N/A
- EPS Growth
- PED N/A
- NBY N/A
- EPS
- PED 0.00
- NBY N/A
- Revenue
- PED $33,999,000.00
- NBY $13,884,000.00
- Revenue This Year
- PED $20.90
- NBY N/A
- Revenue Next Year
- PED $17.10
- NBY $26.04
- P/E Ratio
- PED $238.93
- NBY N/A
- Revenue Growth
- PED 12.92
- NBY 4.06
- 52 Week Low
- PED $0.61
- NBY $0.36
- 52 Week High
- PED $1.10
- NBY $14.35
- Technical
- Relative Strength Index (RSI)
- PED 55.72
- NBY 52.49
- Support Level
- PED $0.88
- NBY $0.64
- Resistance Level
- PED $1.04
- NBY $0.75
- Average True Range (ATR)
- PED 0.05
- NBY 0.08
- MACD
- PED 0.01
- NBY 0.01
- Stochastic Oscillator
- PED 61.35
- NBY 37.25
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.